384 related articles for article (PubMed ID: 25701674)
1. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
6. BCG and Adverse Events in the Context of Leprosy.
Richardus R; van Hooij A; van den Eeden SJF; Wilson L; Alam K; Richardus JH; Geluk A
Front Immunol; 2018; 9():629. PubMed ID: 29670618
[TBL] [Abstract][Full Text] [Related]
7. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
[TBL] [Abstract][Full Text] [Related]
8. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
van Hooij A; van den Eeden SJF; Khatun M; Soren S; Franken KLMC; Chandra Roy J; Alam K; Chowdhury AS; Richardus JH; Geluk A
Vaccine; 2021 Dec; 39(50):7230-7237. PubMed ID: 34688497
[TBL] [Abstract][Full Text] [Related]
9. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.
Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S
PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040
[TBL] [Abstract][Full Text] [Related]
10. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts.
Goulart IM; Bernardes Souza DO; Marques CR; Pimenta VL; Gonçalves MA; Goulart LR
Clin Vaccine Immunol; 2008 Jan; 15(1):101-5. PubMed ID: 17989339
[TBL] [Abstract][Full Text] [Related]
11. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
12. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
13. Active search for leprosy cases in Midwestern Brazil: a serological evaluation of asymptomatic household contacts before and after prophylaxis with bacillus Calmette-Guérin.
Limeira OM; Gomes CM; Morais OO; Cesetti MV; Alvarez RR
Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740009
[TBL] [Abstract][Full Text] [Related]
14. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
15.
Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
Front Immunol; 2018; 9():2920. PubMed ID: 30631322
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Schuring RP; Richardus JH; Pahan D; Oskam L
Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
[TBL] [Abstract][Full Text] [Related]
17. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
Chen X; You YG; Yuan YH; Yuan LC; Wen Y
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
[TBL] [Abstract][Full Text] [Related]
18. Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.
Sarno EN; Espinosa M; Sampaio EP; Vieira LM; Figueiredo AA; Miranda CF; Esquenazi D; Salgado JL; Nogueira N
Braz J Med Biol Res; 1988; 21(3):461-70. PubMed ID: 3147795
[TBL] [Abstract][Full Text] [Related]
19. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]